SlideShare a Scribd company logo
The words "anticipates“, “wishes”, “expects”, "estimates“, “intends“,
"forecasts“, "plans“, "predicts“, "projects“, "targets" and similar words are
intended to identify these statements, which necessarily involve known
and unknown risks and uncertainties.
Known risks and uncertainties include, but are not limited to, the impact of
competitive products and pricing, market acceptance of products,
product transitions by the Company and its competitors, regulatory
approval, currency fluctuations, production and supply difficulties,
changes in product sales mix, and other risks.
This presentation also includes pro-forma information prepared by the
Company for information and reference purposes only, which has not
been audited. Forward-looking statements speak only as of the date they
are made, and the Company does not undertake any obligation to
update them in light of new information or future developments.
www.natura.net/investor
DISCLAIMER
This presentation contains
forward-looking statements.
Such statements are not
statements of historical fact,
and reflect the beliefs and
expectations of Natura &Co's
management.
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
1
2
4
3
¹
•
•
•
•
•
•
•
billion¹
million
+ billion
#1
#2 #7
¹
•
•
•
•
•
Limited portfolio
Complete portfolio
¹
³
¹
² ²
³
²
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
2
1
3
1 2 3
1 2 3
1 3
SOURCE: Kantar | Euromonitor | Natura & Co –Financials. Team Analysis.
9 potential markets
Ecuador
Guatemala
Dominican Republic
Costa Rica
Uruguay
Panama
Paraguay
Honduras
El Salvador
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
❑
❑
❑
❑
❑
❑
❑
❑
❑
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
•
•
•
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
40
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
43
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
•
•
•
•
•
•
•
•
6
£2.2m
45
CONFIDENTIAL – THE BODY SHOP LTD
•
•
•
•
•
46
46
CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
47
CONFIDENTIAL – THE BODY SHOP LTD
11 new products
across 5 categories
First flagship concept launched,
Aesop Sydney
Travel retail concepts launched
in Melbourne and Seoul
Further expansion of our global
presence and customer base
• 37 new locations
• 16 relocations
• 1 office relocation
• Entered Netherlands
• 1.5M active customers
(+180K vs. CY18)
• ~20,000 hours volunteered
• Aesop Foundation committed
~US$1.2M to support
marginalised communities and
literacy
• ~US$300K of product donations
to charitable causes
Continued support for our
communities globally
Significant steps on our
continuing sustainability journey
• Recycled PET launched
across >70% of range
(>90% by end 2020)
• Refill screw-cap 5 SKUs
• Rinse & Return program
trial in HK: 1.8 tonnes
returned
• As always, our range remains entirely
vegan and cruelty free
Compassion and opportunity
Rapid scale-up of capacity and
fulfilment capability
Traffic and conversion growth Enhanced our online
customer experience
New digital partnerships to
expand our customer reach
• Sales growth currently > +500% YOY
• Conversion lift 4x
• Improved SEM / SEO to drive traffic
• Upgraded digital
technology
• Every day exceeds
highest previous
capacity
• Converted 8 stores to
fulfilment locations
• New channels
to customer
• Mobile
optimization
• LiveChat expansion, select rollout of
WeChat, exploring Line and Kakao Talk
• Increased supply to
existing digital
wholesale partnerships
• Commencing new
wholesale partnerships
i.e AmazonUS
Strengthening our customer
connection
Continuing growth of our
China-focused channels
Preparing for physical entry
• Strengthen brand presence on
channels of choice
• KOL engagement strategy
• China-specific marketing program
• Customer workshops conducted in
Beijing and Shanghai
• Strengthening local capability
• Opening Shanghai office
• Building local team
• Exploring values-aligned physical
entry in partnership with Cruelty Free
International
• Developing plans for experiential
House of Aesop concept in Shanghai
• Continue growth of Tmall, Aesop’s
gateway to the Chinese customer
since 2018 (~US$9m sales, 112K
transactions, 214K enquiries)
• Continue growth of Little Red Book,
Feelunique.cn and other platforms
Natura investor day 2020
Natura investor day 2020
Natura investor day 2020
Natura investor day 2020
Natura investor day 2020

More Related Content

Similar to Natura investor day 2020

Smart & Final Investor Relations Handout September 2017
Smart & Final Investor Relations Handout September 2017Smart & Final Investor Relations Handout September 2017
Smart & Final Investor Relations Handout September 2017
SmartFinalIR
 
Smart and Final handout September 2017
Smart and Final handout September 2017Smart and Final handout September 2017
Smart and Final handout September 2017
Vladimir Rizun
 
Sfs ir handout_september_2017
Sfs ir handout_september_2017Sfs ir handout_september_2017
Sfs ir handout_september_2017
Sara Lenz, PMP
 
Vocera investordeck may 12 2017 needham
Vocera investordeck   may 12 2017 needhamVocera investordeck   may 12 2017 needham
Vocera investordeck may 12 2017 needham
vocera2016ir
 
Symantec Corporate Presentation
Symantec Corporate PresentationSymantec Corporate Presentation
Symantec Corporate Presentation
InvestorSymantec
 
Demand media ir deck 08.08.16 website version
Demand media ir deck 08.08.16 website versionDemand media ir deck 08.08.16 website version
Demand media ir deck 08.08.16 website version
Leaf Group
 
Evine investor presentation sept 2016 final
Evine investor presentation sept 2016 finalEvine investor presentation sept 2016 final
Evine investor presentation sept 2016 final
evine2015
 
Evine investor presentation sept 2016
Evine investor presentation sept 2016Evine investor presentation sept 2016
Evine investor presentation sept 2016
evine2015
 
Valeant Investor Day 2015 Presentation
Valeant Investor Day 2015 PresentationValeant Investor Day 2015 Presentation
Valeant Investor Day 2015 Presentation
Valeant_Pharmaceuticals
 
Demand media ir deck 08.05.16
Demand media ir deck 08.05.16Demand media ir deck 08.05.16
Demand media ir deck 08.05.16
Leaf Group
 
1001205101
10012051011001205101
1001205101
veriskir
 
Lowe's before C&C investor power point
Lowe's before C&C investor power pointLowe's before C&C investor power point
Lowe's before C&C investor power point
sseligson
 
Sfs ir handout may 2018 v1
Sfs ir handout may 2018 v1Sfs ir handout may 2018 v1
Sfs ir handout may 2018 v1
SmartFinalIR
 
2016 05 instructure q2 2016 ir pdf
2016 05 instructure q2 2016 ir pdf2016 05 instructure q2 2016 ir pdf
2016 05 instructure q2 2016 ir pdf
Instructure
 
Nu Skin Investor Day 2022 Slides.pdf
Nu Skin Investor Day 2022 Slides.pdfNu Skin Investor Day 2022 Slides.pdf
Nu Skin Investor Day 2022 Slides.pdf
YmirMGarcia
 
William blair-35th-annual-growth-stock-conference
William blair-35th-annual-growth-stock-conferenceWilliam blair-35th-annual-growth-stock-conference
William blair-35th-annual-growth-stock-conference
Quintiles2014
 
Internet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.com
Internet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.comInternet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.com
Internet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.com
Aaron Magness
 
Barclays healthcare final
Barclays healthcare finalBarclays healthcare final
Barclays healthcare final
Quintiles2014
 
Jefferies 5.11.16 v final pdf
Jefferies 5.11.16 v final pdfJefferies 5.11.16 v final pdf
Jefferies 5.11.16 v final pdf
Instructure
 
Evine investor presentation november 2016
Evine investor presentation november 2016Evine investor presentation november 2016
Evine investor presentation november 2016
evine2015
 

Similar to Natura investor day 2020 (20)

Smart & Final Investor Relations Handout September 2017
Smart & Final Investor Relations Handout September 2017Smart & Final Investor Relations Handout September 2017
Smart & Final Investor Relations Handout September 2017
 
Smart and Final handout September 2017
Smart and Final handout September 2017Smart and Final handout September 2017
Smart and Final handout September 2017
 
Sfs ir handout_september_2017
Sfs ir handout_september_2017Sfs ir handout_september_2017
Sfs ir handout_september_2017
 
Vocera investordeck may 12 2017 needham
Vocera investordeck   may 12 2017 needhamVocera investordeck   may 12 2017 needham
Vocera investordeck may 12 2017 needham
 
Symantec Corporate Presentation
Symantec Corporate PresentationSymantec Corporate Presentation
Symantec Corporate Presentation
 
Demand media ir deck 08.08.16 website version
Demand media ir deck 08.08.16 website versionDemand media ir deck 08.08.16 website version
Demand media ir deck 08.08.16 website version
 
Evine investor presentation sept 2016 final
Evine investor presentation sept 2016 finalEvine investor presentation sept 2016 final
Evine investor presentation sept 2016 final
 
Evine investor presentation sept 2016
Evine investor presentation sept 2016Evine investor presentation sept 2016
Evine investor presentation sept 2016
 
Valeant Investor Day 2015 Presentation
Valeant Investor Day 2015 PresentationValeant Investor Day 2015 Presentation
Valeant Investor Day 2015 Presentation
 
Demand media ir deck 08.05.16
Demand media ir deck 08.05.16Demand media ir deck 08.05.16
Demand media ir deck 08.05.16
 
1001205101
10012051011001205101
1001205101
 
Lowe's before C&C investor power point
Lowe's before C&C investor power pointLowe's before C&C investor power point
Lowe's before C&C investor power point
 
Sfs ir handout may 2018 v1
Sfs ir handout may 2018 v1Sfs ir handout may 2018 v1
Sfs ir handout may 2018 v1
 
2016 05 instructure q2 2016 ir pdf
2016 05 instructure q2 2016 ir pdf2016 05 instructure q2 2016 ir pdf
2016 05 instructure q2 2016 ir pdf
 
Nu Skin Investor Day 2022 Slides.pdf
Nu Skin Investor Day 2022 Slides.pdfNu Skin Investor Day 2022 Slides.pdf
Nu Skin Investor Day 2022 Slides.pdf
 
William blair-35th-annual-growth-stock-conference
William blair-35th-annual-growth-stock-conferenceWilliam blair-35th-annual-growth-stock-conference
William blair-35th-annual-growth-stock-conference
 
Internet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.com
Internet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.comInternet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.com
Internet Retailer Conference + Exhibition (IRCE) 2013 - Coastal.com
 
Barclays healthcare final
Barclays healthcare finalBarclays healthcare final
Barclays healthcare final
 
Jefferies 5.11.16 v final pdf
Jefferies 5.11.16 v final pdfJefferies 5.11.16 v final pdf
Jefferies 5.11.16 v final pdf
 
Evine investor presentation november 2016
Evine investor presentation november 2016Evine investor presentation november 2016
Evine investor presentation november 2016
 

Recently uploaded

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 

Recently uploaded (20)

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 

Natura investor day 2020

  • 1.
  • 2. The words "anticipates“, “wishes”, “expects”, "estimates“, “intends“, "forecasts“, "plans“, "predicts“, "projects“, "targets" and similar words are intended to identify these statements, which necessarily involve known and unknown risks and uncertainties. Known risks and uncertainties include, but are not limited to, the impact of competitive products and pricing, market acceptance of products, product transitions by the Company and its competitors, regulatory approval, currency fluctuations, production and supply difficulties, changes in product sales mix, and other risks. This presentation also includes pro-forma information prepared by the Company for information and reference purposes only, which has not been audited. Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them in light of new information or future developments. www.natura.net/investor DISCLAIMER This presentation contains forward-looking statements. Such statements are not statements of historical fact, and reflect the beliefs and expectations of Natura &Co's management.
  • 3.
  • 5.
  • 9.
  • 10.
  • 11. ¹
  • 13.
  • 15.
  • 18.
  • 19.
  • 21.
  • 23. 2 1 3 1 2 3 1 2 3 1 3
  • 24. SOURCE: Kantar | Euromonitor | Natura & Co –Financials. Team Analysis. 9 potential markets Ecuador Guatemala Dominican Republic Costa Rica Uruguay Panama Paraguay Honduras El Salvador
  • 25.
  • 26.
  • 27.
  • 29.
  • 30.
  • 32.
  • 33.
  • 34. CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 35.
  • 36.
  • 38. CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 39. CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 40. 40 CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 41. CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 42. CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 43. 43 CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020 • • • • • • • •
  • 45. 45 CONFIDENTIAL – THE BODY SHOP LTD • • • • •
  • 46. 46 46 CONFIDENTIAL – THE BODY SHOP INTERNATIONAL LIMITED 2020
  • 47. 47 CONFIDENTIAL – THE BODY SHOP LTD
  • 48.
  • 49.
  • 50. 11 new products across 5 categories First flagship concept launched, Aesop Sydney Travel retail concepts launched in Melbourne and Seoul Further expansion of our global presence and customer base • 37 new locations • 16 relocations • 1 office relocation • Entered Netherlands • 1.5M active customers (+180K vs. CY18) • ~20,000 hours volunteered • Aesop Foundation committed ~US$1.2M to support marginalised communities and literacy • ~US$300K of product donations to charitable causes Continued support for our communities globally Significant steps on our continuing sustainability journey • Recycled PET launched across >70% of range (>90% by end 2020) • Refill screw-cap 5 SKUs • Rinse & Return program trial in HK: 1.8 tonnes returned • As always, our range remains entirely vegan and cruelty free
  • 52. Rapid scale-up of capacity and fulfilment capability Traffic and conversion growth Enhanced our online customer experience New digital partnerships to expand our customer reach • Sales growth currently > +500% YOY • Conversion lift 4x • Improved SEM / SEO to drive traffic • Upgraded digital technology • Every day exceeds highest previous capacity • Converted 8 stores to fulfilment locations • New channels to customer • Mobile optimization • LiveChat expansion, select rollout of WeChat, exploring Line and Kakao Talk • Increased supply to existing digital wholesale partnerships • Commencing new wholesale partnerships i.e AmazonUS
  • 53.
  • 54. Strengthening our customer connection Continuing growth of our China-focused channels Preparing for physical entry • Strengthen brand presence on channels of choice • KOL engagement strategy • China-specific marketing program • Customer workshops conducted in Beijing and Shanghai • Strengthening local capability • Opening Shanghai office • Building local team • Exploring values-aligned physical entry in partnership with Cruelty Free International • Developing plans for experiential House of Aesop concept in Shanghai • Continue growth of Tmall, Aesop’s gateway to the Chinese customer since 2018 (~US$9m sales, 112K transactions, 214K enquiries) • Continue growth of Little Red Book, Feelunique.cn and other platforms